The NanoBioTechnology Hub

Cardiopulmonary Diagnostics Innovation

Development of miniaturised point-of-care in vitro diagnostics (IVDs) for decentralised cardiopulmonary health monitoring and early diagnosis, using the latest advances in nanotechnology and biotechnology.

We are developing an ultra-sensitive handheld device for pre-hospital biomarker blood analysis.

Upon patient risk stratification, it gives peace of mind if the risk is very low, saving resources to the healthcare system by avoiding hospitalisation. If the risk is low-medium-high, the device, based on the risk, directs the patient to the right department, speeding up triage.

The Hub

A focused synergic network for the technical and commercial success of your projects.

Find your customers, users, KOLs, strategic partners, investors and mentors.

Build your Technology and Innovation roadmap with the major tech, clinical, regulatory and commercial experts in the field.

Biotech Education

Educational and career resources for professionals and students in biotech, nanotech and diagnostics, with tailored support, based on years of academic and industrial experience.

In addition, thanks to our strategic partnership, we have access to a novel AI platform that democratises access to education, boosting diversity and inclusion.

Our old, not-for-profit academic website

Between 2020 and 2025, we pursued academic-industry collaboration with a focus on communication and dissemination.

We co-discovered theAlpha variant of SARS-CoV-2 in the United Kingdom, in 2020, and tracked it effectively, guiding decision-making at the national level through dynamic risk assessment to boost national security. Visit our old website.